Talis Biomedical Corporation (NASDAQ:TLIS) Is Expected To Grow By Or More Than -28.76%.

In last trading session, Talis Biomedical Corporation (NASDAQ:TLIS) saw 0.34 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.66 trading at $0.06 or 1.30% at ring of the bell on the day assigns it a market valuation of $124.14M. That c

Related Keywords

Warren Buffett ,Arrowmark Colorado Holdings ,Vanguard Explorer Fund Inc ,Baker Brothers Advisors ,Meridian Contrarian Fund ,Talis Biomedical Corporation ,Stocks Primed ,Explode The ,Biomedical Corporation ,Vanguard Explorer Fund ,Mutual Funds ,Nasdaq Tlis ,Lis ,Lis Stock , ,